Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Aspen Pharma
Aspen Pharma
Activities:
Distribution
Finance
Pharmaceutical
X
LinkedIn
Trending Articles
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Fasenra for EGPA: addressing unmet needs
Benralizumab could offer patients with EGPA more treatment options, while reducing dependency on oral corticosteroids
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Bristol Myers Squibb and Cellares partner to expand CAR-T manufacturing capabilities
Cellares will optimise and automate select Bristol Myers Squibb CAR-T cell therapies onto its high-throughput manufacturing program, the Cell Shuttle
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
Aspen to expand production facility in South Africa
Durban-based pharma company said it will invest US$320m at its Port Elizabeth site
Media
Lactalis eyes Aspen's infant formula division
The French dairy product manufacturer would boost its potential in the Chinese market if deal is successful
Manufacturing
Aspen Australia recommends SADE SP140 weight sorters
Decision to choose a weight sorter was based on reading online reviews
Finance
Strides to buy drug assets in Australia and Mauritius from Aspen for approximately US$300m
Part of aim to focus on areas where most value can be added, says Strides
Finance
Endo buys portfolio of branded and generic products
Acquisition supports continued growth in South Africa and adds some 60 on-market products and nearly 70 R&D pipeline programmes
Finance
GSK completes partial sale of Aspen Pharmacare Holdings shares
Proceeds from the transaction will be used for general corporate purposes
Finance
GlaxoSmithKline sells thrombosis brands to Aspen for £700m
The transaction includes a manufacturing plant in France
Subscribe now